Evidence map›Paper›PMID 39502970›Full record

ReviewCureus2024

Colorectal Cancer Screening and Management in Low- and Middle-Income Countries and High-Income Countries: A Narrative Review.

Barbara A Abreu Lopez, Rafael Pinto-Colmenarez, Fides Myles C Caliwag, Lorraine Ponce-Lujan, Mariela D Fermin, Ana V Granillo Cortés, Anette G Mejía Martínez, Ismael G Zepeda Martinez, Fernanda Gress León

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Common Risk Factors in Gastrointestinal Cancers: A Narrative Review.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Barbara A Abreu LopezGeneral Medicine, Universidad de Carabobo, Valencia, VEN.
Rafael Pinto-ColmenarezMedicine, Universidad de Carabobo, Valencia, VEN.
Fides Myles C CaliwagGeneral Practice, Ateneo School of Medicine and Public Health, Pasig, PHL.
Lorraine Ponce-LujanGeneral Practice, Universidad de San Martín de Porres, Lima, PER.
Mariela D FerminGeneral Practice, Instituto Tecnológico de Santo Domingo, Santo Domingo, DOM.
Ana V Granillo CortésInternal Medicine, Universidad Nacional Autónoma de México, Ciudad de México, MEX.
Anette G Mejía MartínezInternal Medicine, Universidad Nacional Autónoma de México, Ciudad de México, MEX.
Ismael G Zepeda MartinezInternal Medicine, Universidad Nacional Autónoma de México, Ciudad de México, MEX.
Fernanda Gress LeónInternal Medicine, Saint Luke Escuela de Medicina, Ciudad de México, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) remains a leading global health challenge, being a highly prevalent cancer and a major cause of cancer-related deaths worldwide. The incidence of CRC varies significantly between high-income countries (HICs) and low- and middle-income countries (LMICs), with higher rates of incidence but lower mortality in HICs. Factors such as genetic predisposition, lifestyle, and dietary habits play significant roles in CRC development, with the Western diet and limited access to screening contributing to increased incidence. This review highlights disparities in CRC screening, management, and outcomes between HICs and LMICs, with HICs benefiting from advanced screening methods like colonoscopy and sigmoidoscopy, while LMICs face challenges due to limited healthcare infrastructure and resources. Tailored strategies, including low-cost screening options and community-based initiatives, are critical in LMICs to improve early detection and outcomes. Future directions for improving CRC care globally include telemedicine, artificial intelligence, and mobile health technologies to bridge access gaps, as well as personalized medicine to enhance treatment efficacy. Global collaboration and investment in healthcare infrastructure are necessary to reduce CRC-related mortality, particularly in resource-limited settings.

Indexed as

colonoscopycolorectal cancer (crc)colorectal cancer screeninghigh income countrieslow income countries

Identifiers

PMID39502970
PMCPMC11537780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.